Resveratrol acts not through anti-aggregative pathways but mainly via its scavenging properties against Aβ and Aβ-metal complexes toxicity.
It has been recently suggested that resveratrol can be effective in slowing down Alzheimer's disease (AD) development. As reported in many biochemical studies, resveratrol seems to exert its neuro-protective role through inhibition of β-amyloid aggregation (Aβ), by scavenging oxidants and exert...
Main Authors: | Alberto Granzotto, Paolo Zatta |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2011-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3124535?pdf=render |
Similar Items
-
Resveratrol and Alzheimer’s disease: message in a bottle on red wine and cognition
by: Alberto eGranzotto, et al.
Published: (2014-05-01) -
Effect of Metals on Kinetic Pathways of Amyloid-β Aggregation
by: Francis Hane, et al.
Published: (2014-01-01) -
Aβ Behavior on Neuronal Membranes: Aggregation and Toxicities
by: Katsuhiko Yanagisawa, et al.
Published: (2011-01-01) -
A biophysical study of amyloid-β aggregation and toxicity determinants
by: Bolognesi, Benedetta Maria
Published: (2011) -
Polyphenols with Anti-Amyloid β Aggregation Show Potential Risk of Toxicity Via Pro-Oxidant Properties
by: Hatasu Kobayashi, et al.
Published: (2020-05-01)